FMP
NASDAQ
0.81 USD
-0.1801 (-22.24%)
Dr. Lishan Aklog M.D.
Healthcare
Medical - Devices
https://www.luciddx.com
NASDAQ
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an esophageal cell collection device. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.
0001799011
US54948X1090
54948X109
One Grand Central Place
212 949 4319
US
70
Oct 14, 2021
0001799011
NASDAQ
Medical - Devices
Healthcare
54948X109
US54948X1090
US
0.81
1.73
115.42k
39.07M
-
0.8099-1.85
-0.81
-
-
-
-
-0.64
-
https://www.luciddx.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.